Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FKC289 in Relapsed/Refractory Membranous Nephropathy
NCT07765537Phase 2Not yet recruiting
- Sponsor
- Fosun Kairos
- Start
- Aug 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 2 trial of FKC289 in primary membranous nephropathy (PMN), sponsored by Fosun Kairos. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
FKC289
03
Conditions
primary membranous nephropathy (PMN)
Beyond the preview
Go deeper on NCT07765537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07765537.